Scientists Uncover One of the Driving Forces of Alzheimer’s Disease (applicable to PD) – New Target for Treatment

[PDWarrior1900]

scitechdaily.com/scientists...

"New research explored how a protein called tau, critical to Alzheimer’s, turns from normal to a diseased state. This discovery presents a new target to potentially prevent or treat this debilitating progressive illness that slowly destroys cognitive function and memory. "

"The authors say the new mechanism and the master sites at its center could apply to a range of neurological disorders in which tau is involved, including Parkinson’s disease, concussion-induced chronic brain injury, and stroke."

------------------------------------------------------------------------------------------------

STAY STRONG!

There are currently over 130 world-wide CLINICAL trials for treating PD symptoms AND REVERSING PD!

A 'MIRACLE CURE' is just around the corner!

-----------------------------------------------------------------------------------------------

clinicaltrialsarena.com/ana...

"Four major trials have readouts expected in the next six months, three of which target motor symptoms, also known as dyskinesia. Two trials focus on dyskinesia resulting from sustained use of generic levodopa, which is widely considered the standard of care in PD. A third study tests a new formulation of levodopa that could reduce treatment side effects such as dyskinesia, while a fourth trial takes aim at cognitive impairment in PD."

-------------------------------------------------------------------------------------------------------

GOOGLE (USA trials):

"After excluded levodopa/carbidopa derivative add-on therapies, we identified 47 trials as PD treatment drugs or therapies. Among them, 19 trials are in phase I (41%), 25 trials are in phase II (53%), and 3 trials are in phase III (6%).Jul 25, 2021"